ZEVIA PBC-A (ZVIA)

US98955K1043 - Common Stock

3.18  -0.03 (-0.93%)

After market: 3.01 -0.17 (-5.35%)

Fundamental Rating

3

Taking everything into account, ZVIA scores 3 out of 10 in our fundamental rating. ZVIA was compared to 33 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. ZVIA does not seem to be growing, but still is valued expensively.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZVIA has reported negative net income.
ZVIA had a negative operating cash flow in the past year.
ZVIA had negative earnings in each of the past 5 years.
ZVIA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -29.50%, ZVIA is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
The Return On Equity of ZVIA (-29.65%) is worse than 81.82% of its industry peers.
Industry RankSector Rank
ROA -29.5%
ROE -29.65%
ROIC N/A
ROA(3y)-31.58%
ROA(5y)-25.34%
ROE(3y)-30.18%
ROE(5y)-27.5%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZVIA has a Gross Margin (44.27%) which is comparable to the rest of the industry.
ZVIA's Gross Margin has been stable in the last couple of years.
ZVIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5YN/A

More info and screens

8

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZVIA has more shares outstanding
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZVIA has an Altman-Z score of 400.07. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ZVIA (400.07) is better than 100.00% of its industry peers.
ZVIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 400.07
ROIC/WACCN/A
WACC9.21%

2.3 Liquidity

ZVIA has a Current Ratio of 2.85. This indicates that ZVIA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.85, ZVIA belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
A Quick Ratio of 1.96 indicates that ZVIA should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.96, ZVIA belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 1.96

More info and screens

3

3. Growth

3.1 Past

ZVIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.63%.
Looking at the last year, ZVIA shows a decrease in Revenue. The Revenue has decreased by -6.47% in the last year.
The Revenue has been growing by 14.80% on average over the past years. This is quite good.
EPS 1Y (TTM)2.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)-6.47%
Revenue growth 3Y14.8%
Revenue growth 5YN/A
Sales Q2Q%-15.6%

3.2 Future

The Earnings Per Share is expected to grow by 19.26% on average over the next years. This is quite good.
ZVIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.95% yearly.
EPS Next Y26.33%
EPS Next 2Y20.73%
EPS Next 3Y19.26%
EPS Next 5YN/A
Revenue Next Year-6.72%
Revenue Next 2Y0.2%
Revenue Next 3Y3.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVIA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZVIA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ZVIA's earnings are expected to grow with 19.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.73%
EPS Next 3Y19.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZVIA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEVIA PBC-A

NYSE:ZVIA (12/20/2024, 8:04:00 PM)

After market: 3.01 -0.17 (-5.35%)

3.18

-0.03 (-0.93%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners36.92%
Inst Owner Change-5.12%
Ins Owners44.92%
Ins Owner Change-0.17%
Market Cap232.17M
Analysts78.33
Price Target2.4 (-24.53%)
Short Float %1.23%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.57%
Min EPS beat(2)13.21%
Max EPS beat(2)49.94%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)3.92%
Max EPS beat(4)49.94%
EPS beat(8)8
Avg EPS beat(8)29.61%
EPS beat(12)11
Avg EPS beat(12)24.46%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.63%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)1.78%
Revenue beat(4)1
Avg Revenue beat(4)-2.9%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)1.78%
Revenue beat(8)4
Avg Revenue beat(8)0.47%
Revenue beat(12)5
Avg Revenue beat(12)-0.62%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28.42%
PT rev (3m)28.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)1.62%
EPS NY rev (3m)11.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.77%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-2.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.51
P/FCF N/A
P/OCF N/A
P/B 3.2
P/tB 3.35
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS2.1
BVpS0.99
TBVpS0.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.5%
ROE -29.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.27%
FCFM N/A
ROA(3y)-31.58%
ROA(5y)-25.34%
ROE(3y)-30.18%
ROE(5y)-27.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5YN/A
F-Score5
Asset Turnover2.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.18%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.85
Quick Ratio 1.96
Altman-Z 400.07
F-Score5
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)202.14%
Cap/Depr(5y)150.35%
Cap/Sales(3y)1.61%
Cap/Sales(5y)1.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y26.33%
EPS Next 2Y20.73%
EPS Next 3Y19.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.47%
Revenue growth 3Y14.8%
Revenue growth 5YN/A
Sales Q2Q%-15.6%
Revenue Next Year-6.72%
Revenue Next 2Y0.2%
Revenue Next 3Y3.95%
Revenue Next 5YN/A
EBIT growth 1Y4.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.54%
EBIT Next 3Y26.92%
EBIT Next 5YN/A
FCF growth 1Y78.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.6%
OCF growth 3YN/A
OCF growth 5YN/A